← Open Payments lookup

ALBERT NGUYEN: Open Payments

NPI 1992124986 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$776 in 27 payments from 10 companies in 2025. Trend: 2023 $786 · 2024 $1,382 · 2025 $776

Food & beverage: $776
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$159
E.R. Squibb & Sons, L.L.C.3$148
Axsome Therapeutics, Inc.1$125
Otsuka America Pharmaceutical, Inc.3$68
Alkermes, Inc.3$61
Janssen Pharmaceuticals, Inc3$52
ABBVIE INC.3$51
Teva Pharmaceuticals USA, Inc.3$48
Vanda Pharmaceuticals Inc.2$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28

Products named: INGREZZA, COBENFY, Auvelity, REXULTI, ARISTADA, VRAYLAR, AUSTEDO XR, FANAPT.

Industry payments across CA — which companies pay providers there.